NewMed Energy - Limited Partnership Logo

NewMed Energy - Limited Partnership

NWMD.TA

(2.5)
Stock Price

902,00 ILA

12.69% ROA

34.46% ROE

6.74x PER

Market Cap.

3.187.297.836,14 ILA

119.77% DER

6.59% Yield

42.77% NPM

NewMed Energy - Limited Partnership Stock Analysis

NewMed Energy - Limited Partnership Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

NewMed Energy - Limited Partnership Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (30.38%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 Net Profit Growth

Throughout the past five years, this company has consistently experienced net profit growth, indicating a strong financial performance and making it an attractive investment prospect.

3 Dividend

With a solid track record of dividend payments over the past five years, the company has established itself as a dependable choice for investors seeking consistent income.

4 ROA

The stock's ROA (9.56%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 PBV

The stock's PBV ratio (2.22x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

6 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

7 Assets Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

8 DER

The stock is burdened with a heavy load of debt (157%), making it financially unstable and potentially risky for investors.

9 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

10 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (7), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

NewMed Energy - Limited Partnership Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

NewMed Energy - Limited Partnership Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

NewMed Energy - Limited Partnership Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

NewMed Energy - Limited Partnership Revenue
Year Revenue Growth
2004 27.029.169
2005 32.221.087 16.11%
2006 49.861.602 35.38%
2007 61.110.953 18.41%
2008 76.488.000 20.1%
2009 89.368.000 14.41%
2010 118.082.000 24.32%
2011 184.321.000 35.94%
2012 116.463.000 -58.27%
2013 204.897.000 43.16%
2014 230.089.000 10.95%
2015 247.114.000 6.89%
2016 271.063.000 8.84%
2017 501.926.000 46%
2018 457.982.000 -9.6%
2019 453.344.000 -1.02%
2020 919.122.000 50.68%
2021 882.537.000 -4.15%
2022 1.143.900.000 22.85%
2023 1.143.200.000 -0.06%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

NewMed Energy - Limited Partnership Research and Development Expenses
Year Research and Development Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

NewMed Energy - Limited Partnership General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 405.243
2005 719.783 43.7%
2006 703.383 -2.33%
2007 715.288 1.66%
2008 746.000 4.12%
2009 780.000 4.36%
2010 2.638.000 70.43%
2011 3.377.000 21.88%
2012 4.111.000 17.85%
2013 4.451.000 7.64%
2014 3.863.000 -15.22%
2015 4.758.000 18.81%
2016 4.907.000 3.04%
2017 10.629.000 53.83%
2018 9.811.000 -8.34%
2019 7.975.000 -23.02%
2020 10.882.000 26.71%
2021 13.139.000 17.18%
2022 13.400.000 1.95%
2023 20.000.000 33%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

NewMed Energy - Limited Partnership EBITDA
Year EBITDA Growth
2004 21.280.929
2005 31.105.000 31.58%
2006 43.277.389 28.13%
2007 54.319.608 20.33%
2008 68.721.000 20.96%
2009 56.647.000 -21.31%
2010 71.519.000 20.79%
2011 120.511.000 40.65%
2012 72.711.000 -65.74%
2013 173.842.000 58.17%
2014 168.870.000 -2.94%
2015 188.422.000 10.38%
2016 224.770.000 16.17%
2017 996.038.000 77.43%
2018 384.974.000 -158.73%
2019 333.870.000 -15.31%
2020 740.557.000 54.92%
2021 659.361.000 -12.31%
2022 873.600.000 24.52%
2023 836.000.000 -4.5%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

NewMed Energy - Limited Partnership Gross Profit
Year Gross Profit Growth
2004 23.252.462
2005 27.593.261 15.73%
2006 44.337.804 37.77%
2007 55.490.833 20.1%
2008 71.050.000 21.9%
2009 62.933.000 -12.9%
2010 83.777.000 24.88%
2011 132.928.000 36.98%
2012 35.192.000 -277.72%
2013 72.853.000 51.69%
2014 134.913.000 46%
2015 147.252.000 8.38%
2016 181.254.000 18.76%
2017 283.744.000 36.12%
2018 279.151.000 -1.65%
2019 236.416.000 -18.08%
2020 535.483.000 55.85%
2021 518.108.000 -3.35%
2022 701.700.000 26.16%
2023 746.000.000 5.94%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

NewMed Energy - Limited Partnership Net Profit
Year Net Profit Growth
2004 15.771.572
2005 9.726.522 -62.15%
2006 31.600.237 69.22%
2007 39.720.784 20.44%
2008 47.375.000 16.16%
2009 38.327.000 -23.61%
2010 49.987.000 23.33%
2011 70.063.000 28.65%
2012 14.640.000 -378.57%
2013 61.150.000 76.06%
2014 70.455.000 13.21%
2015 111.548.000 36.84%
2016 158.454.000 29.6%
2017 817.222.000 80.61%
2018 276.833.000 -195.2%
2019 223.690.000 -23.76%
2020 365.120.000 38.74%
2021 405.072.000 9.86%
2022 469.700.000 13.76%
2023 471.600.000 0.4%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

NewMed Energy - Limited Partnership Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 1 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

NewMed Energy - Limited Partnership Free Cashflow
Year Free Cashflow Growth
2004 22.416.490
2005 20.610.435 -8.76%
2006 37.599.525 45.18%
2007 48.720.496 22.83%
2008 56.113.000 13.17%
2009 8.091.000 -593.52%
2010 -3.252.000 348.8%
2011 -152.627.000 97.87%
2012 -311.269.000 50.97%
2013 -94.050.000 -230.96%
2014 11.232.000 937.34%
2015 71.547.000 84.3%
2016 90.986.000 21.36%
2017 -114.057.000 179.77%
2018 -486.040.000 76.53%
2019 -355.908.000 -36.56%
2020 163.590.000 317.56%
2021 423.254.000 61.35%
2022 405.800.000 -4.3%
2023 87.000.000 -366.44%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

NewMed Energy - Limited Partnership Operating Cashflow
Year Operating Cashflow Growth
2004 22.416.490
2005 20.610.435 -8.76%
2006 37.599.525 45.18%
2007 48.720.496 22.83%
2008 67.103.000 27.39%
2009 54.259.000 -23.67%
2010 69.224.000 21.62%
2011 113.540.000 39.03%
2012 48.070.000 -136.2%
2013 122.809.000 60.86%
2014 100.527.000 -22.17%
2015 141.299.000 28.86%
2016 171.162.000 17.45%
2017 329.272.000 48.02%
2018 258.146.000 -27.55%
2019 254.018.000 -1.63%
2020 328.675.000 22.71%
2021 453.641.000 27.55%
2022 504.700.000 10.12%
2023 127.800.000 -294.91%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

NewMed Energy - Limited Partnership Capital Expenditure
Year Capital Expenditure Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 10.990.000 100%
2009 46.168.000 76.2%
2010 72.476.000 36.3%
2011 266.167.000 72.77%
2012 359.339.000 25.93%
2013 216.859.000 -65.7%
2014 89.295.000 -142.86%
2015 69.752.000 -28.02%
2016 80.176.000 13%
2017 443.329.000 81.92%
2018 744.186.000 40.43%
2019 609.926.000 -22.01%
2020 165.085.000 -269.46%
2021 30.387.000 -443.28%
2022 98.900.000 69.28%
2023 40.800.000 -142.4%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

NewMed Energy - Limited Partnership Equity
Year Equity Growth
2005 62.014.565
2006 73.071.573 15.13%
2007 87.909.093 16.88%
2008 93.122.000 5.6%
2009 131.449.000 29.16%
2010 181.278.000 27.49%
2011 252.054.000 28.08%
2012 268.229.000 6.03%
2013 330.480.000 18.84%
2014 301.861.000 -9.48%
2015 341.978.000 11.73%
2016 409.110.000 16.41%
2017 618.478.000 33.85%
2018 855.104.000 27.67%
2019 813.507.000 -5.11%
2020 997.695.000 18.46%
2021 938.538.000 -6.3%
2022 1.287.400.000 27.1%
2023 1.460.400.000 11.85%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

NewMed Energy - Limited Partnership Assets
Year Assets Growth
2005 194.779.783
2006 193.035.490 -0.9%
2007 191.764.593 -0.66%
2008 191.803.000 0.02%
2009 201.012.000 4.58%
2010 321.935.000 37.56%
2011 623.254.000 48.35%
2012 961.984.000 35.21%
2013 1.104.920.000 12.94%
2014 1.376.866.000 19.75%
2015 1.394.165.000 1.24%
2016 1.517.992.000 8.16%
2017 3.055.503.000 50.32%
2018 3.771.375.000 18.98%
2019 4.503.073.000 16.25%
2020 4.584.687.000 1.78%
2021 3.850.136.000 -19.08%
2022 3.939.000.000 2.26%
2023 3.727.700.000 -5.67%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

NewMed Energy - Limited Partnership Liabilities
Year Liabilities Growth
2005 132.765.217
2006 119.963.917 -10.67%
2007 103.855.500 -15.51%
2008 98.681.000 -5.24%
2009 69.563.000 -41.86%
2010 140.657.000 50.54%
2011 371.200.000 62.11%
2012 693.755.000 46.49%
2013 774.440.000 10.42%
2014 1.075.005.000 27.96%
2015 1.052.187.000 -2.17%
2016 1.108.882.000 5.11%
2017 2.437.025.000 54.5%
2018 2.916.271.000 16.43%
2019 3.689.566.000 20.96%
2020 3.586.992.000 -2.86%
2021 2.911.598.000 -23.2%
2022 2.651.600.000 -9.81%
2023 2.267.300.000 -16.95%

NewMed Energy - Limited Partnership Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.94
Net Income per Share
0.4
Price to Earning Ratio
6.74x
Price To Sales Ratio
2.88x
POCF Ratio
5.72
PFCF Ratio
7.52
Price to Book Ratio
2.18
EV to Sales
4.45
EV Over EBITDA
6.07
EV to Operating CashFlow
8.82
EV to FreeCashFlow
11.6
Earnings Yield
0.15
FreeCashFlow Yield
0.13
Market Cap
3,19 Bil.
Enterprise Value
4,92 Bil.
Graham Number
3.36
Graham NetNet
-1.88

Income Statement Metrics

Net Income per Share
0.4
Income Quality
1.18
ROE
0.34
Return On Assets
0.13
Return On Capital Employed
0.19
Net Income per EBT
0.8
EBT Per Ebit
0.87
Ebit per Revenue
0.62
Effective Tax Rate
0.2

Margins

Sales, General, & Administrative to Revenue
0.02
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.64
Operating Profit Margin
0.62
Pretax Profit Margin
0.53
Net Profit Margin
0.43

Dividends

Dividend Yield
0.07
Dividend Yield %
6.59
Payout Ratio
0.44
Dividend Per Share
0.18

Operating Metrics

Operating Cashflow per Share
0.47
Free CashFlow per Share
0.36
Capex to Operating CashFlow
-0.24
Capex to Revenue
-0.12
Capex to Depreciation
-1.45
Return on Invested Capital
0.17
Return on Tangible Assets
0.13
Days Sales Outstanding
0
Days Payables Outstanding
106.69
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
3.42
Inventory Turnover
0
Capex per Share
-0.11

Balance Sheet

Cash per Share
0,05
Book Value per Share
1,24
Tangible Book Value per Share
1.24
Shareholders Equity per Share
1.24
Interest Debt per Share
1.6
Debt to Equity
1.2
Debt to Assets
0.47
Net Debt to EBITDA
2.14
Current Ratio
3.21
Tangible Asset Value
1,46 Bil.
Net Current Asset Value
-1,84 Bil.
Invested Capital
1.2
Working Capital
0,30 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,11 Bil.
Average Inventory
0
Debt to Market Cap
0.55

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

NewMed Energy - Limited Partnership Dividends
Year Dividends Growth
2005 6
2006 6 16.67%
2007 20 70%
2008 13 -66.67%
2009 6 -100%
2014 18 66.67%
2015 9 -100%
2016 5 -125%
2017 84 95.24%
2018 11 -663.64%
2019 23 50%
2020 16 -46.67%
2021 17 11.76%
2022 36 51.43%
2023 14 -169.23%

NewMed Energy - Limited Partnership Profile

About NewMed Energy - Limited Partnership

NewMed Energy - Limited Partnership engages in the exploration, development, production, and sale of petroleum, natural gas, and condensate in Israel and Cyprus. The company holds interests in the Leviathan project, which covers an area of 500 square kilometer (km2) located to the west of the shores of Haifa; the Block 12 that covers an area of approximately 386 km2 located in Cyprus; and the Yam Tethys project, which covers an area of approximately 500 km2 located to the west of the shores of Ashkelon. It also holds interests in the Boujdour Atlantique exploration license that covers an area of approximately 33,812 km2 located in the south of the Moroccan exclusive economic zone; and the Tanin and Karish leases covering an area of approximately 500km2 located to the west of the shores of Nahariya. The company serves independent power producers, marketing companies, and industrial customers, as well as exports natural gas to Jordan and in Egypt. NewMed Energy Management Ltd. serves as the general partner of the company. The company was formerly known as Delek Drilling - Limited Partnership and changed its name to NewMed Energy - Limited Partnership in February 2022. NewMed Energy - Limited Partnership was incorporated in 1993 and is based in Herzliya, Israel. NewMed Energy - Limited Partnership is a subsidiary of Delek Energy Systems Ltd.

CEO
Mr. Yossi Abu
Employee
24
Address
19 Abba Even Boulevard
Herzliya, 4672537

NewMed Energy - Limited Partnership Executives & BODs

NewMed Energy - Limited Partnership Executives & BODs
# Name Age
1 Mr. Yossi Abu
Chief Executive Officer of NewMed Energy Management Ltd
70
2 Varda Yashar
Principal Account Manager
70
3 Mr. Yehuda Bruker
Chief Engineer of NewMed Energy Management Ltd
70
4 Mr. Nadav Perry
Vice President of Regulatory & Public affairs of NewMed Energy Management Ltd
70
5 Mr. Tzachi Habusha
Vice President of Finance & Chief Financial Officer of NewMed Energy Management Ltd
70
6 Eviatar Arviv
Managing Director of New Ventures & Country Manager
70
7 Mr. Zvi Karcz
Vice President of Exploration & Chief Geologist of NewMed Energy Management Ltd
70
8 Mr. Guil Bashan
Principal Analyst & Director of Investor Relations of NewMed Energy Management Ltd
70
9 Shiran Bozikovsky
C.I.S.O of NewMed Energy Management Ltd
70
10 Ms. Sherry Singer Kaufman
Executive Vice President & General Counsel of NewMed Energy Management Ltd
70

NewMed Energy - Limited Partnership Competitors